Utah Medical Products (NASDAQ:UTMD) Earns "Sell (D+)" Rating from Weiss Ratings

Key Points

• Weiss Ratings has restated a "sell (D+)" rating for Utah Medical Products, indicating potential concerns regarding the stock's performance.
• Utah Medical Products' recent quarterly earnings revealed $0.82 earnings per share with a revenue of $9.81 million, alongside a robust net margin of 30.08%.
• Institutional investors have significantly increased their holdings in Utah Medical Products, with some firms boosting their stakes by over 150% in recent quarters.

Utah Medical Products (NASDAQ:UTMD - Get Free Report)'s stock had its "sell (d+)" rating restated by Weiss Ratings in a research report issued to clients and investors on Friday,Weiss Ratings reports.

Utah Medical Products Price Performance

Shares of NASDAQ UTMD traded down $0.02 during mid-day trading on Friday, hitting $60.43. 5,252 shares of the stock traded hands, compared to its average volume of 7,020. Utah Medical Products has a twelve month low of $51.26 and a twelve month high of $68.99. The company has a market cap of $193.98 million, a PE ratio of 17.08 and a beta of 0.32. The firm has a 50 day simple moving average of $61.64 and a two-hundred day simple moving average of $57.41.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last released its quarterly earnings data on Thursday, October 23rd. The medical instruments supplier reported $0.82 earnings per share for the quarter. Utah Medical Products had a return on equity of 9.90% and a net margin of 30.08%.The company had revenue of $9.81 million for the quarter.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. First Horizon Advisors Inc. lifted its holdings in Utah Medical Products by 159.7% during the 2nd quarter. First Horizon Advisors Inc. now owns 587 shares of the medical instruments supplier's stock worth $33,000 after buying an additional 361 shares during the period. CWM LLC lifted its holdings in Utah Medical Products by 287.4% during the 2nd quarter. CWM LLC now owns 829 shares of the medical instruments supplier's stock worth $47,000 after buying an additional 615 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Utah Medical Products by 156.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier's stock worth $50,000 after buying an additional 546 shares during the period. Golden State Wealth Management LLC lifted its holdings in Utah Medical Products by 100.0% during the 1st quarter. Golden State Wealth Management LLC now owns 1,000 shares of the medical instruments supplier's stock worth $56,000 after buying an additional 500 shares during the period. Finally, State of Wyoming acquired a new position in Utah Medical Products during the 2nd quarter worth about $132,000. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.